Invention Grant
- Patent Title: Antibodies against human and canine IL-13RA2
-
Application No.: US16866736Application Date: 2020-05-05
-
Publication No.: US11655299B2Publication Date: 2023-05-23
- Inventor: Waldemar Debinski , Denise Mazess Herpai
- Applicant: Wake Forest University Health Sciences
- Applicant Address: US NC Winston-Salem
- Assignee: Wake Forest University Health Sciences
- Current Assignee: Wake Forest University Health Sciences
- Current Assignee Address: US NC Winston-Salem
- Agency: Myers Bigel, P.A.
- The original application number of the division: US15835566 2017.12.08
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; G01N33/58 ; G01N33/60 ; A61K47/68 ; A61K49/00 ; C12N9/00 ; A61K47/69 ; A61K39/00
Abstract:
Provided herein are monoclonal antibodies that specifically bind IL-13RA2 with cross-reactivity in humans and canines. Also provided are methods of use of the antibodies in the treatment and monitoring of cancers.
Public/Granted literature
- US20200299394A1 ANTIBODIES AGAINST HUMAN AND CANINE IL-13RA2 Public/Granted day:2020-09-24
Information query
